In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Francisco Sierra-LópezDepartment of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, Av. Instituto Politécnico Nacional 2508, Zacatenco, Mexico City 07360, Mexico.ORCID 0000-0002-4467-773X Juan Carlos Fernández-HernándezHealth Research Unit, Hospital Regional de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR) México, Carr Mex-Puebla Km 34.5 col., Zoquiapan, Mexico City 56530, Mexico.ORCID 0009-0000-9776-0396 Lidia Baylón-PachecoDepartment of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, Av. Instituto Politécnico Nacional 2508, Zacatenco, Mexico City 07360, Mexico.ORCID 0000-0002-8405-8159 Verónica Ivonne Hernández-RamírezDepartment of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, Av. Instituto Politécnico Nacional 2508, Zacatenco, Mexico City 07360, Mexico.ORCID 0000-0002-1743-939X Juan Carlos Bravata-AlcántaraHealth Research Unit, Hospital Regional de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR) México, Carr Mex-Puebla Km 34.5 col., Zoquiapan, Mexico City 56530, Mexico.ORCID 0000-0002-3585-0051 Vanessa Iglesias-VázquezHealth Research Unit, Hospital Regional de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR) México, Carr Mex-Puebla Km 34.5 col., Zoquiapan, Mexico City 56530, Mexico.ORCID 0009-0008-5111-2738 Susana Bernardo-HernándezHealth Research Unit, Hospital Regional de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR) México, Carr Mex-Puebla Km 34.5 col., Zoquiapan, Mexico City 56530, Mexico.ORCID 0009-0009-6027-0129 Daniel Medrano-EspinosaDepartment of Oncology, Hospital Regional de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR) México, Carr Mex-Puebla Km 34.5 col., Zoquiapan, Mexico City 56530, Mexico.ORCID 0009-0006-1957-5578 Gustavo Acosta-AltamiranoHospital General de México, Eje 2A Sur (Dr. Balmis) No. 148, Cuauhtémoc, Doctores, CDMX, Mexico City 06726, Mexico.ORCID 0000-0002-5623-6683 Patricia Talamás-RohanaDepartment of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, Av. Instituto Politécnico Nacional 2508, Zacatenco, Mexico City 07360, Mexico.ORCID 0000-0002-5085-814X José Luis Rosales-EncinaDepartment of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, Av. Instituto Politécnico Nacional 2508, Zacatenco, Mexico City 07360, Mexico.ORCID 0000-0002-5207-2909 Mónica Sierra-MartínezHealth Research Unit, Hospital Regional de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR) México, Carr Mex-Puebla Km 34.5 col., Zoquiapan, Mexico City 56530, Mexico.ORCID 0000-0002-1006-592X Funding
Consejo Nacional de Humanidades Ciencias y Tecnologías (CONAHCyT), Mexico Grant 104119
6 · The paper itselfAbstract
Ovarian cancer (OC) is usually diagnosed at an advanced stage, contributing to its high mortality rate. The presence of concurrent bacterial infections in these patients is a common clinical observation, and the mechanisms by which this coinfection influences tumor progression are still not fully understood. This study investigates the role of polydisperse extracellular vesicles (PEVs) secreted by OC cells in response to bacterial components, aiming to elucidate a potential communication pathway between OC and the bacterial microenvironment. We stimulated a human OC cell line in vitro with a fraction of
Indexed as
Cell-Derived MicroparticlesCoinfectionEscherichia coliEscherichia coli InfectionsExtracellular VesiclesOvarian NeoplasmsCell Line, TumorFemaleHumansProteomicsTumor MicroenvironmentEVsovarian cancerPEVsSKOV-3 line
Identifiers
PMID41226690
PMCPMC12608175
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390